Page last updated: 2024-11-07

2-aminomethyl-4-t-butyl-6-iodophenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-aminomethyl-4-t-butyl-6-iodophenol: has gastric antisecretory activity; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119286
CHEMBL ID279581
SCHEMBL ID888409
MeSH IDM0061770

Synonyms (17)

Synonym
mk-447
phenol, 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodo-
mk 447
2-aminomethyl-4-t-butyl-6-iodophenol
2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol
CHEMBL279581
2-(aminomethyl)-4-tert-butyl-6-iodophenol
58456-91-0
SCHEMBL888409
SSEAPVMQZPKNQZ-UHFFFAOYSA-N
2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol
DTXSID00207153
CS-0018449
HY-100297
FT-0737268
2-aminomethyl-4-tert-butyl-6-iodophenol
AKOS040733753

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"MK-447-(14)C [2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride] was well absorbed and metabolized in man, rats, and dogs."( Physiological disposition and metabolism of 2-aminomethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride.
Arison, BH; deLuna, FA; Duncan, AE; Tocco, DJ; Vandenheuvel, WJ; Walker, RW,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID58596The saluretic(K+) effect of compound was measured in dogs after iv administration at 3 mg/kg dose; K+mequiv/min=201981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176006The saluretic(Cl-) effect of compound was measured in rats after oral administration at 3 mg/kg dose; Cl-mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID173381The saluretic(K+) effect of compound was measured in rats after oral administration at 9 mg/kg dose; K+mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID175998The saluretic (Na+) effect of compound was measured in rats after oral administration at 27 mg/kg dose; Na+ mequiv*100/cage1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID185744Mean arterial pressure was measured in hypertensive rat at dose of 20 mg/kg, ip1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID193070Duration of effect was measured in hypertensive rat1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID173380The saluretic(K+) effect of compound was measured in rats after oral administration at 81 mg/kg dose; K+mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176003The saluretic(Cl-) effect of compound was measured in rats after oral administration at 27 mg/kg dose; Cl-mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176010The saluretic(K+) effect of compound was measured in rats after oral administration at 27 mg/kg dose; K+mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID58594The saluretic(Cl-) effect of compound was measured in dogs after iv administration at 3 mg/kg dose; Cl-mequiv/min=3031981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID58598The saluretic(Na+) effect of compound was measured in dogs after iv administration at 3 mg/kg dose; Na+ mequiv/min=2791981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176008The saluretic(Cl-) effect of compound was measured in rats after oral administration at 81 mg/kg dose; Cl-mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176009The saluretic(Cl-) effect of compound was measured in rats after oral administration at 9 mg/kg dose; Cl-mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID175999The saluretic (Na+) effect of compound was measured in rats after oral administration at 81 mg/kg dose; Na+ mequiv*100/cage1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176013The saluretic(K+) effect of compound was measured in rats after oral administration at 3 mg/kg dose; K+mequiv*100/cage=141981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID176000The saluretic (Na+) effect of compound was measured in rats after oral administration at 9 mg/kg dose; Na+ mequiv*100/cage1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID185745Mean arterial pressure was measured in hypertensive rat at dose of 20 mg/kg, po1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
AID175997Saluretic(Na+) effect of compound was measured in rats after oral administration at 3 mg/kg dose; Na+ mequiv*100/cage1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (70.27)18.7374
1990's9 (24.32)18.2507
2000's1 (2.70)29.6817
2010's1 (2.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.45 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (7.32%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (92.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]